Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics

The sense of hearing is vulnerable to environmental challenges, such as exposure to noise. More than 1.5 billion people experience some decline in hearing ability during their lifetime, of whom at least 430 million will be affected by disabling hearing loss. If not identified and addressed in a time...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (5793 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545265704498
ctrlnum (CKB)5400000000043169
(oapen)https://directory.doabooks.org/handle/20.500.12854/76840
(EXLCZ)995400000000043169
collection bib_alma
record_format marc
spelling Vlajkovic, Srdjan M edt
Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (5793 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
The sense of hearing is vulnerable to environmental challenges, such as exposure to noise. More than 1.5 billion people experience some decline in hearing ability during their lifetime, of whom at least 430 million will be affected by disabling hearing loss. If not identified and addressed in a timely way, hearing loss can severely reduce the quality of life at various stages. Some causes of hearing loss can be prevented, for example from occupational or leisure noise. The World Health Organization estimates that more than 1 billion young people put themselves at risk of permanent hearing loss by listening to loud music over long periods of time. Mitigating such risks through public health action is essential to reduce the impact of hearing loss in the community. The etiology of sensorineural hearing loss is complex and multifactorial, arising from congenital and acquired causes. This book highlights the diverse range of approaches to sensorineural hearing loss, from designing new animal models of age-related hearing loss, to the use of microRNAs as biomarkers of cochlear injury and drug repurposing for the therapy of age-related and noise-induced hearing loss. Further investigation into the underlying molecular mechanisms of sensorineural hearing loss and the integration of the novel drug, cell, and gene therapy strategies into controlled clinical studies will permit significant advances in a field where there are currently many unmet needs.
English
Medicine bicssc
brain-derived neurotrophic factor
TrkB
inner ear
development
zebrafish
mitochondria dysfunction
reactive oxygen species
hypoxic
d-galactose
high-fat diet
aging
hearing loss
astrocytes
auditory brainstem
lateral superior olive
gap junctions
voltage-activated calcium channel 1.3
otoferlin
spontaneous activity
deafness
circadian dysregulation
clock genes
noise-induced hearing loss
sensory hair cells
synaptic ribbons
sensorineural hearing loss
hyperbaric oxygenation
adjunctive therapy
microRNAs
cochlear nucleus
inferior colliculus
neuroplasticity
noise-induced cochlear injury
cochlear rescue
otoprotection
adenosine A1 receptor
regulator of G protein signalling 4
CCG-4986
intratympanic drug delivery
potassium voltage-gated channel subfamily q member 4
potassium
nonsyndromic hearing loss
KCNQ4 activator
age-related hearing loss
selegiline
chronic oral treatment
hearing protection
mouse model
3-0365-1506-2
3-0365-1505-4
Vlajkovic, Srdjan M oth
language English
format eBook
author2 Vlajkovic, Srdjan M
author_facet Vlajkovic, Srdjan M
author2_variant s m v sm smv
author2_role Sonstige
title Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
spellingShingle Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_full Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_fullStr Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_full_unstemmed Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_auth Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_new Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
title_sort molecular mechanisms of sensorineural hearing loss and development of inner ear therapeutics
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (5793 p.)
isbn 3-0365-1506-2
3-0365-1505-4
illustrated Not Illustrated
work_keys_str_mv AT vlajkovicsrdjanm molecularmechanismsofsensorineuralhearinglossanddevelopmentofinnereartherapeutics
status_str n
ids_txt_mv (CKB)5400000000043169
(oapen)https://directory.doabooks.org/handle/20.500.12854/76840
(EXLCZ)995400000000043169
carrierType_str_mv cr
is_hierarchy_title Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
author2_original_writing_str_mv noLinkedField
_version_ 1796648820002521088
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04082nam-a2200865z--4500</leader><controlfield tag="001">993545265704498</controlfield><controlfield tag="005">20231214132847.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/76840</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043169</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vlajkovic, Srdjan M</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (5793 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The sense of hearing is vulnerable to environmental challenges, such as exposure to noise. More than 1.5 billion people experience some decline in hearing ability during their lifetime, of whom at least 430 million will be affected by disabling hearing loss. If not identified and addressed in a timely way, hearing loss can severely reduce the quality of life at various stages. Some causes of hearing loss can be prevented, for example from occupational or leisure noise. The World Health Organization estimates that more than 1 billion young people put themselves at risk of permanent hearing loss by listening to loud music over long periods of time. Mitigating such risks through public health action is essential to reduce the impact of hearing loss in the community. The etiology of sensorineural hearing loss is complex and multifactorial, arising from congenital and acquired causes. This book highlights the diverse range of approaches to sensorineural hearing loss, from designing new animal models of age-related hearing loss, to the use of microRNAs as biomarkers of cochlear injury and drug repurposing for the therapy of age-related and noise-induced hearing loss. Further investigation into the underlying molecular mechanisms of sensorineural hearing loss and the integration of the novel drug, cell, and gene therapy strategies into controlled clinical studies will permit significant advances in a field where there are currently many unmet needs.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain-derived neurotrophic factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TrkB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inner ear</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">development</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">zebrafish</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mitochondria dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactive oxygen species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypoxic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">d-galactose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">high-fat diet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">astrocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">auditory brainstem</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lateral superior olive</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gap junctions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">voltage-activated calcium channel 1.3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">otoferlin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spontaneous activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">deafness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circadian dysregulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clock genes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">noise-induced hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sensory hair cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synaptic ribbons</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sensorineural hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyperbaric oxygenation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adjunctive therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cochlear nucleus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inferior colliculus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuroplasticity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">noise-induced cochlear injury</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cochlear rescue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">otoprotection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adenosine A1 receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">regulator of G protein signalling 4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CCG-4986</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intratympanic drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">potassium voltage-gated channel subfamily q member 4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">potassium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nonsyndromic hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KCNQ4 activator</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">age-related hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">selegiline</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chronic oral treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hearing protection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mouse model</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1506-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1505-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vlajkovic, Srdjan M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:34:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337862270004498&amp;Force_direct=true</subfield><subfield code="Z">5337862270004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337862270004498</subfield></datafield></record></collection>